The Latest

The board will release new proposed revisions and seeks additional public comments.

A group of attorneys raises concerns about extensive industry ties among FINRA’s public board members.

Jennifer Geimer, Ph.D. is a managing research scientist in product research and development at CEB, now Gartner. Geimer works with a team of researchers to develop engaging multimedia simulations and situational judgment tests. She has presented research on gamification at professional conferences and co-authored a book chapter on serious games in personnel selection. This blog first appeared on the CEB Blogs site.

The standard process for launching exchange traded funds is flawed, argues Allan Roth. He proposes a better way.

Suzanne Delbanco is the executive director of Catalyst for Payment Reform, an independent, nonprofit corporation that aims help employers and other healthcare purchasers get better value for their healthcare dollar. CPR’s membership includes Walmart, Boeing, GE, 3M, Google and Wells Fargo. Suzanne is one of the nation’s leading experts on payment reform and transparency in healthcare and advises employers on strategies for managing their health spend, benefit design. She has been included on Modern Healthcare’s list of the 100 Most Influential People in Healthcare.

“Your risk of being audited goes up,” says RIA powerhouse Ron Carson.

A 75-year-old widowed retiree allegedly lost nearly half of her $3 million investment in the scheme.

Like lagging retail giants, wealth management firms risk ruin by failing to recognize changing customer expectations or by squandering the opportunity to evolve their business model.

Here's a chance for young advisors to join the ranking of elite talent.

The rule’s impact could be “devastating if independent research ceases or is significantly diminished,” the manager warns.